Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion.
Journal: JCO Precision Oncology
Published:
Abstract
Polyclonal convergent evolution to PARPi resistance in a patient with metastatic breast cancer with gPALB2.
Authors
Maria Fatteh, Jaime Wehr, Katerina Karaindrou, Rena Xian, Christopher Gocke, Ming-tseh Lin, Dana Petry, Kala Visvanathan, Rima Couzi, Cesar Santa Maria, Vered Stearns, Jessica Tao, Valsamo Anagnostou, Jenna Canzoniero
Relevant Conditions